---
title: "Guggenheim Sticks to Its Buy Rating for Liberty Media Liberty Formula One (FWONA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294205709.md"
description: "Guggenheim analyst maintained a Buy rating on Liberty Media Liberty Formula One today and set a price target of $116.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Currently, the analyst consensus on Liberty Media Liberty Formula One is a Strong Buy with an average price target of $113.50."
datetime: "2026-07-29T12:12:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294205709.md)
  - [en](https://longbridge.com/en/news/294205709.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294205709.md)
generator: "portal-rs"
---

# Guggenheim Sticks to Its Buy Rating for Liberty Media Liberty Formula One (FWONA)

Guggenheim analyst maintained a Buy rating on Liberty Media Liberty Formula One today and set a price target of $116.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Currently, the analyst consensus on Liberty Media Liberty Formula One is a Strong Buy with an average price target of $113.50.

### Related Stocks

- [FWONA.US](https://longbridge.com/en/quote/FWONA.US.md)
- [FWONK.US](https://longbridge.com/en/quote/FWONK.US.md)

## Related News & Research

- [Liberty Formula One Completes $690 Million Convertible Notes Offering](https://longbridge.com/en/news/295849084.md)
- [Telsey Advisory Sticks to Their Buy Rating for Abercrombie Fitch (ANF)](https://longbridge.com/en/news/296366488.md)
- [Lowe’s Earns Buy Rating as Strong Earnings and Cash Generation Offset Lower-End Guidance](https://longbridge.com/en/news/296383656.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)
- [OpenAI Codex lead points to sub2api as users report shrinking limits](https://longbridge.com/en/news/296611126.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**